For immunochemical detection of the progesterone receptor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Progesterone Receptor (C-Term) Rabbit Monoclonal Antibody (Clone RM357)

Item No. 32308

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Synonyms
  • NR3C3
  • Nuclear Receptor Subfamily 3 Group C Member 3
Immunogen
Peptide from the C-terminal region of the progesterone receptor
Clone Designation
RM357
Formulation (Request formulation change)
100 µl of protein A-affinity purified monoclonal antibody
Storage Buffer
PBS with 50% glycerol, 1% BSA, and 0.09% sodium azide
Host
Rabbit
Isotype
IgG
Applications
IHC, WB
Cross Reactivity
(+) Progesterone receptor α(+) Progesterone receptor β
Species Reactivity
(+) Human
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    100 µl

    $411

    Add
    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    The progesterone receptor is a ligand-dependent transcription factor and member of the nuclear steroid hormone receptor family encoded by PGR in humans.1 It is composed of a C-terminal ligand-binding domain, a central globular DNA-binding domain, and an intrinsically disordered N-terminal domain. It is expressed primarily in the CNS and female reproductive tissues, where it has roles in maintaining cognitive flexibility and reproductive biology, respectively, as well as in bone and the cardiovascular system.1,2 Two active isoforms of the progesterone receptor, N-terminally truncated progesterone receptor A and full-length progesterone receptor B, are produced by transcription of PGR using two promoters, and function as an inhibitor and activator of transcription, respectively. The inactive progesterone receptor is localized to the cytosol and assembled into an inactive multiprotein chaperone complex, which is essential for maintaining the progesterone receptor in a ligand-binding competent state. Progesterone binding to the inactive progesterone receptor induces a conformational change, dissociation of chaperones, dimerization, and nuclear translocation, resulting in modulation of gene transcription. Progesterone receptor levels are increased in uterine leiomyoma tissue compared with normal myometrium in patients with uterine fibroids and progesterone receptor expression is associated with favorable overall survival and recurrence-free survival in patients with ovarian cancer.3,4 Cayman’s Progesterone Receptor (C-Term) Rabbit Monoclonal Antibody (Clone RM357) can be used for immunohistochemistry (IHC) and Western blot (WB) applications.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Grimm, S.L., Hartig, S.M., and Edwards, D.P. Progesterone receptor signaling mechanisms. J. Mol. Biol. 428(19), 3831-3849 (2016).

    2. Scarpin, K.M., Graham, J.D., Mote, P.A., et al. Progesterone action in human tissues: Regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression. Nucl. Recept. Signal. 7, e009 (2009).

    3. Patel, B., Elguero, S., Thakore, S., et al. Role of nuclear progesterone receptor isoforms in uterine pathophysiology. Hum. Reprod. Update 21(2), 155-173 (2015).

    4. Luo, H., Li, S., Zhao, M., et al. Prognostic value of progesterone receptor expression in ovarian cancer: A meta-analysis. Oncotarget 8(22), 36845-36856 (2017).